Earnings History Data for MOONLAKE IMMUNO (MLTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
MOONLAKE IMMUNO
MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
07-11-2024 | PM | MLTX | MOONLAKE IMMUNO | 3,043 | -0.56 | -0.44 | 0.00 | 50.64 | -0.84 (-1.63%) |
51.48 | 0.0 (0.00%) |
35.53 - 64.98 | 211,046 | 260,000 | 18,964 | |||
|
||||||||||||||||||
07-08-2024 | PM | MLTX | MOONLAKE IMMUNO | 2,667 | -0.39 | -0.28 | 0.00 | MoonLake Immunotherapeutics GAAP EPS of -$0.39 [8/7/2024 9:34 AM] |
42.86 | -1.07 (-2.44%) |
44.42 | 0.49 (1.12%) |
35.11 - 64.98 | 327,228 | 330,000 | 249 | ||
07-05-2024 | PM | MLTX | MOONLAKE IMMUNO | 2,892 | -0.22 | -0.21 | 0.00 | MoonLake Immunotherapeutics EPS of -$0.22 misses by $0.01 [5/7/2024 12:15 PM] |
43.75 | -0.77 (-1.73%) |
43.01 | -1.51 (-3.39%) |
24.31 - 64.98 | 267,662 | 310,000 | 292 | ||
14-11-2023 | PM | MLTX | MoonLake Immunotherapeutics | 2,360 | -0.18 | -0.22 | -0.27 | MoonLake Immunotherapeutics GAAP EPS of -$0.18 beats by $0.04 [11/14/2023 2:41 PM] |
39.25 | 1.85 (4.95%) |
37.40 | 0.0 (0.00%) |
7.89 - 63.40 | 581,465 | 1,390,000 | 21,506 | ||
10-08-2023 | PM | MLTX | MOONLAKE IMMUNO | 2,859 | -0.23 | -0.25 | 0.00 | MoonLake Immunotherapeutics GAAP EPS of -$0.23 beats by $0.02 [8/10/2023 12:10 PM] |
54.56 | 0.33 (0.61%) |
54.70 | 0.47 (0.87%) |
5.36 - 63.40 | 205,933 | 420,000 | 1,000 | ||
12-05-2023 | PM | MLTX | MOONLAKE IMMUNO | 1,488 | -0.23 | -0.28 | 0.00 | MoonLake Immunotherapeutics GAAP EPS of -$0.23 [5/12/2023 9:17 AM] |
27.62 | 0.92 (3.45%) |
27.25 | 0.55 (2.06%) |
4.25 - 29.59 | 210,831 | 400,000 | 184 | ||
14-11-2022 | PM | 0:00 AM ET (Nov 14) |
MLTX | MOONLAKE IMMUNO | 123.00 | -0.27 | -0.32 | 0.00 | GAAP EPS of -$0.27 beats by $0.07 [11/14/2022 9:27 AM] |
8.98 | 0.02 (0.22%) |
0.0 | 0.0 (0.00%) |
4.25 - 15.19 | 12,157 | 10,000 | 0 | |